Company / Working Capital
Day One Biopharmaceuticals, Inc. Working Capital History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$424.6M
FY2025
5-year range
$280.7M / $488.9M
FY2021-FY2025
Trend
-13.2%
vs FY2024
Sector context
#105 of 215
Health Care
What the data says
At $425M, Day One Biopharmaceuticals, Inc.'s working capital ranks #105 of 215 in the Health Care sector. Improved from $346M to $425M over the past 2 years.
Based on SEC 10-K filings.
$425M in FY2025 with a 5-year CAGR of +58.0%.
Improved from $346M to $425M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +8.6%
- 5-Year CAGR
- +58.0%
- 10-Year CAGR
- -
Sector benchmark
#105 of 215 in Health CareTop 49% of 215This company $424.6M Sector average $957.8M
▼
-55.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +58.0%, indicating consistent growth.
- In FY2025, working capital decreased 13.2% year-over-year.
- Ranks #105 out of 215 companies in the Health Care sector.
- Peak working capital was recorded in FY2024.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $424.6M | -13.2% |
| FY2024 | $488.9M | +41.4% |
| FY2023 | $345.8M | +4.4% |
| FY2022 | $331.3M | +18.0% |
| FY2021 | $280.7M | +551.7% |
| FY2020 | $43.1M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026